Actinium Says Phase 3 SIERRA Trial Results Of Iomab-B Shows Improving OS For AML Patients

RTTNews | 945 hari yang lalu
Actinium Says Phase 3 SIERRA Trial Results Of Iomab-B Shows Improving OS For AML Patients

(RTTNews) - Actinium Pharmaceuticals, Inc. (ATNM) announced Thursday that results from the Phase 3 SIERRA trial of Iomab-B were presented in an oral presentation at the 50th Annual European Bone Marrow Transplant Society Meeting (EBMT) held in Glasgow, Scotland on April 14-17.

The results showed that an Iomab-B led bone marrow transplant (BMT) results in higher rates of remissions and durable Complete Remission (dCR), which is the primary endpoint of the SIERRA trial, as well as significant improvement in overall survival in TP53 positive patients.

Iomab-B is a targeted radiotherapeutic comprised of an anti-CD45 monoclonal antibody with the Iodine-131 radioisotope payload.

The Phase 3 SIERRA trial enrolled 153 patients age 55 and above with active relapsed or refractory acute myeloid leukemia (AML) and compared outcomes of patients receiving Iomab-B BMT to those of patients receiving physician's choice of care in the control arm.

In total, 24% (37/153) of the patients enrolled on SIERRA had a TP53 mutation, which is associated with limited treatment options and poor outcomes.

baca selengkapnya
Walmart Q3 Net Profit Drops, Despite Sales Growth; Lifts FY27 Outlook

Walmart Q3 Net Profit Drops, Despite Sales Growth; Lifts FY27 Outlook

Retail giant Walmart Inc. reported Thursday lower profit in its third quarter of fiscal 2027, mainly on the absence of prior year's significant gain on equity, while operating income climbed with growth in U.S. comparable sales and eCommerce performance. Meanwhile, U.S. comparable sales growth was slower than last year. Further, the company lifted fiscal 2027 forecast again.
RTTNews | 1 jam 39 menit yang lalu
Bay Street Headed For Positive Start

Bay Street Headed For Positive Start

Higher Canadian and U.S. futures point to a firm start for the Canadian market Thursday morning. Tech stocks are seen moving higher amid renewed optimism about AI trade following Anthropic's record IPO offering.
RTTNews | 1 jam 42 menit yang lalu
U.S. Weekly Jobless Claims Unexpectedly Inch Higher

U.S. Weekly Jobless Claims Unexpectedly Inch Higher

First-time claims for U.S. unemployment benefits unexpectedly edged slightly higher in the week ended November 14th, according to a report released by the Labor Department on Thursday.
RTTNews | 1 jam 52 menit yang lalu
Euro Rises As Risk-Appetite Improves

Euro Rises As Risk-Appetite Improves

The euro strengthened against other major currencies in the European session on Thursday, as European stocks edged higher after three days of losses. Technology stocks were rising after Anthropic raised $81.3 billion in the largest stock-market debut on record.
RTTNews | 2 jam 52 menit yang lalu
Euro Rises Against Majors

Euro Rises Against Majors

The euro strengthened against other major currencies in the European session on Thursday.
RTTNews | 3 jam 31 menit yang lalu
FTSE 100 Hovers Near 6-Week Lows On Consumer Sector Decline

FTSE 100 Hovers Near 6-Week Lows On Consumer Sector Decline

The FTSE 100 dropped to 10,524.60, down 0.25%, as consumer sector losses offset gains elsewhere. Investec fell 6.6% and JD Sports Fashion dropped 4.2% after cutting profit guidance. Mulberry plunged 22% despite turnaround progress.
RTTNews | 3 jam 45 menit yang lalu
NZ Dollar Rises Amid Risk-on Mood

NZ Dollar Rises Amid Risk-on Mood

The New Zealand dollar strengthened against other major currencies in the European session on Thursday, as European stocks traded higher after three days of losses. Technology stocks were rising after Anthropic raised $81.3 billion in the largest stock-market debut on record.
RTTNews | 3 jam 49 menit yang lalu